Novo Nordisk Restructures Domestic Footprint as Oral Wegovy Pill Outpaces Rival
Novo Nordisk’s oral semaglutide outperforms Eli Lilly’s drug in obesity trial, while the company halts Odense plant construction.…
Browsing Tag